These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38699798)

  • 1. Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome.
    Kim DH; Hong J; Shin DY; Kim I; Yoon SS; Bang SM; Lee JO; Lee JY; Kim SA; Byun JM; Koh Y
    Br J Haematol; 2024 Jul; 205(1):356-359. PubMed ID: 38699798
    [No Abstract]   [Full Text] [Related]  

  • 2. Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome.
    Kadia TM; Borthakur G; Garcia-Manero G; Faderl S; Jabbour E; Estrov Z; York S; Huang X; Pierce S; Brandt M; Koller C; Kantarjian HM; Ravandi F
    Br J Haematol; 2012 May; 157(3):312-20. PubMed ID: 22360602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome.
    Garg R; Faderl S; Garcia-Manero G; Cortes J; Koller C; Huang X; York S; Pierce S; Brandt M; Beran M; Borthakur G; Kantarjian H; Ravandi F
    Leukemia; 2009 Jul; 23(7):1297-302. PubMed ID: 19242494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.
    Kim H; Lee JH; Joo YD; Bae SH; Hyun MS; Lee JH; Kim DY; Lee WS; Ryoo HM; Kim MK; Park JH; Lee KH;
    Ann Hematol; 2012 Sep; 91(9):1459-69. PubMed ID: 22526363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.
    Afable MG; Shaik M; Sugimoto Y; Elson P; Clemente M; Makishima H; Sekeres MA; Lichtin A; Advani A; Kalaycio M; Tiu RV; O'Keefe CL; Maciejewski JP
    Haematologica; 2011 Sep; 96(9):1269-75. PubMed ID: 21606164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.
    Cho SY; Lee DG; Choi SM; Choi JK; Lee HJ; Kim SH; Park SH; Choi JH; Yoo JH; Kim YJ; Kim HJ; Min WS
    Mycoses; 2015 Sep; 58(9):565-71. PubMed ID: 26214656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
    Dahlén T; Kalin M; Cederlund K; Nordlander A; Björkholm M; Ljungman P; Blennow O
    Eur J Haematol; 2016 Feb; 96(2):175-80. PubMed ID: 25880378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome.
    Phillips K; Cirrone F; Ahuja T; Siegfried J; Papadopoulos J
    J Oncol Pharm Pract; 2019 Mar; 25(2):398-403. PubMed ID: 30319061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
    Ananda-Rajah MR; Grigg A; Downey MT; Bajel A; Spelman T; Cheng A; Thursky KT; Vincent J; Slavin MA
    Haematologica; 2012 Mar; 97(3):459-63. PubMed ID: 22058198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posaconazole prophylaxis in hematologic cancer.
    van Nieuwkoop C; van Dissel JT
    N Engl J Med; 2007 May; 356(21):2215; author reply 2215-8. PubMed ID: 17526089
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy with anti-thymocyte globulin in severe aplastic anemia].
    González N; Arranz R; Fernández-Garese D; Lozano M; Vázquez L; Fernández-Rañada JM
    Sangre (Barc); 1986; 31(1):17-22. PubMed ID: 3704881
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-thymocyte globulin in haematology: Recent developments.
    Siddiqui S; Cox J; Herzig R; Palaniyandi S; Hildebrandt GC; Munker R
    Indian J Med Res; 2019 Sep; 150(3):221-227. PubMed ID: 31719292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-thymocyte globulin therapy induced a spurious increase of fibrinogen degradation products in hypoplastic myelodysplastic syndrome.
    Yahata Y; Isobe Y; Sasaki M; Oshimi K; Sugimoto K
    Eur J Haematol; 2009 May; 82(5):404. PubMed ID: 19191866
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction.
    Komrokji RS; Mailloux AW; Chen DT; Sekeres MA; Paquette R; Fulp WJ; Sugimori C; Paleveda-Pena J; Maciejewski JP; List AF; Epling-Burnette PK
    Haematologica; 2014 Jul; 99(7):1176-83. PubMed ID: 24488560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
    Scheinberg P; Nunez O; Wu C; Young NS
    Br J Haematol; 2006 Jun; 133(6):606-11. PubMed ID: 16704434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antilymphocyte globulin for mesalazine-associated aplastic anaemia.
    Laidlaw ST; Reilly JT
    Lancet; 1994 Apr; 343(8903):981-2. PubMed ID: 7909039
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of anti-thymocyte globulin combined with Chinese medicine drugs for shen-nourishing in treating acute aplastic anemia].
    Liu F; Li L; Liu C
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):768-70. PubMed ID: 20929142
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term risk of cancer development in adult patients with idiopathic aplastic anemia after treatment with anti-thymocyte globulin.
    van der Hem JGK; de Wreede LC; Brand A; Veelken H; Falkenburg JHF; Halkes CJM
    Haematologica; 2017 Oct; 102(10):e382-e383. PubMed ID: 28705902
    [No Abstract]   [Full Text] [Related]  

  • 19. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
    N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis-associated aplastic anaemia treated successfully with antilymphocyte globulin.
    Bhattacharyya M; Oakervee H; Dalley C; Glynn M; Cavenagh J
    Clin Lab Haematol; 2005 Oct; 27(5):331-3. PubMed ID: 16178916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.